Clinical Trial Update: Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating dihydroartemisinin for Polycystic Ovary Syndrome and is currently recruiting. The sponsor is Shanghai Zhongshan Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Dihydroartemisinin (dihydroartemisinin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Polycystic Ovary Syndrome (PCOS) | Phase 2 | Status: RECRUITING